Hologic, Inc. (Nasdaq: HOLX), a leading medical technology company dedicated to improving women’s health, today announced new data that highlights how the company’s advanced AI-powered mammography ...

“These results underscore AI’s ability to make breast cancer screening more accurate and efficient, and its potential to provide valuable insights about each patient’s unique tumor biology,” said Mark ...

HOLX's Breast Health unit is back in focus as a proposed Blackstone-TPG deal adds a $76 cash offer and CVR to 2026-27 revenue goals.

New data on Hologic’s (Nasdaq: HOLX) breast cancer detection technologies will be presented at the Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago ...

Between 2016 and 2019, researchers at a top-tier medical facility conducted 7,500 digital breast tomosynthesis (3D ...

Hologic has put forward more data bolstering the use of its artificial intelligence programs for detecting breast cancer through mammography. The study, conducted at Massachusetts General Hospital and ...

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - imaging, diagnostics ...

Research suggests AI may help identify more aggressive breast cancers and perform comparably to experts in breast cancer screening MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Data from two groundbreaking ...

In a retrospective study conducted at Massachusetts General Hospital, researchers analyzed 5,000 digital breast tomosynthesis (3D mammography) screening exams performed between 2016 and 2019 using ...